Table of Contents

COVID-19 Vaccine Associated Transverse Myelitis

Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Myelitis, including Transverse Myelitis

Acute myelitis and ChAdOx1 nCoV-19 vaccine: coincidental or causal association

Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222)

Transverse myelitis induced by SARS-CoV-2 vaccination

Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 (AZD1222) vaccine.

Acute transverse myelitis after COVID-19 vaccination.

Extensive longitudinal transverse myelitis after ChAdOx1 nCOV-19 vaccine: case report.

Acute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature.

Acute transverse myelitis following inactivated COVID-19 vaccine

Acute transverse myelitis after COVID-19 vaccination.

A case of longitudinally extensive transverse myelitis following Covid-19 vaccination

Post COVID-19 transverse myelitis; a case report with review of the literature.

Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2

Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination.

Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination.

Longitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccine